Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles

 
• By Xu Hu
  
Obesity management
Chinese biopharma firms are building their R&D presence in obesity but face multiple challenges in the developing domestic sector. (Shutterstock)

More from China

More from Therapy Areas